Expertise in
27
conditions

Dr. Marwan N. Sabbagh

Neurology
CommonSpirit Health
Barrow MAMDC And Barrow Cognitive
240 W Thomas Rd, Ste 301, 
Phoenix, AZ 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
27
conditions
CommonSpirit Health
Barrow MAMDC And Barrow Cognitive
240 W Thomas Rd, Ste 301, 
Phoenix, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Marwan Sabbagh is a Neurologist in Phoenix, Arizona. Dr. Sabbagh is highly rated in 27 conditions, according to our data. His top areas of expertise are Alzheimer's Disease, Dementia, Lewy Body Dementia (LBD), Movement Disorders, and Deep Brain Stimulation. Dr. Sabbagh is currently accepting new patients.

His clinical research consists of co-authoring 311 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Arizona
Residency
Baylor College of Medicine
Specialties
Neurology
Licenses
Psychiatry & Neurology in CA
Board Certifications
Psychiatry & Neurology (Neurology)
Fellowships
San Diego Veterans Affairs Medical Center
Hospital Affiliations
St Josephs Hospital And Medical Center
Chandler Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PacificSource
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Barrow MAMDC and Barrow Cognitive
240 W Thomas Rd, Ste 301, Phoenix, AZ 85013
Call: 602-406-6262

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Enrollment Status: Recruiting
Publish Date: November 21, 2024
Escitalopram for Agitation in Alzheimer's Disease
Escitalopram for Agitation in Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drug: Escitalopram
Study Phase: Phase 3
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Enrollment Status: Completed
Publish Date: November 20, 2024
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Trial Ready Cohort for the Prevention of Alzheimer's Dementia (TRC-PAD)
Trial Ready Cohort for the Prevention of Alzheimer's Dementia (TRC-PAD)
Enrollment Status: Completed
Publish Date: June 27, 2024
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Enrollment Status: Completed
Publish Date: December 28, 2023
Intervention Type: Drug
Study Drug: Solanezumab
Study Phase: Phase 3
Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease
Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
Therapeutic Effects of Exercise in Adults With Amnestic Mild Cognitive Impairment (MCI)
Therapeutic Effects of Exercise in Adults With Amnestic Mild Cognitive Impairment (MCI)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Drug
Study Drug: LY3002813
Study Phase: Phase 2
A Phase Ib Multi-Center, Double-Blind, Randomized, Placebo-Controlled Dose Escalation Study of the Safety, Tolerability and Immunogenicity of ACI-24 in Adults With Down Syndrome
A Phase Ib Multi-Center, Double-Blind, Randomized, Placebo-Controlled Dose Escalation Study of the Safety, Tolerability and Immunogenicity of ACI-24 in Adults With Down Syndrome
Enrollment Status: Completed
Publish Date: October 15, 2021
Intervention Type: Biological
Study Phase: Phase 1
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 3
Longitudinal Assessment of Amyloid Positron Emission Tomography (PET), Fludeoxyglucose F18 (FDG) PET, Tau PET, Magnetic Resonance Imaging (MRI), and Blood Spot Ribonucleic Acid (RNA) in Down Syndrome Individuals With and Without Alzheimer's Dementia and Normal Controls
Longitudinal Assessment of Amyloid Positron Emission Tomography (PET), Fludeoxyglucose F18 (FDG) PET, Tau PET, Magnetic Resonance Imaging (MRI), and Blood Spot Ribonucleic Acid (RNA) in Down Syndrome Individuals With and Without Alzheimer's Dementia and Normal Controls
Enrollment Status: Completed
Publish Date: October 29, 2019
Intervention Type: Procedure, Other
Study Phase: Not Applicable
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 12 Less Clinical Trials

311 Total Publications

Correlations of CSF Biomarkers of Alzheimer's Disease with Cognitive Measures in MCI and AD Dementia: A Cross-Sectional Analysis.
Correlations of CSF Biomarkers of Alzheimer's Disease with Cognitive Measures in MCI and AD Dementia: A Cross-Sectional Analysis.
Journal: Research square
Published: December 11, 2025
View All 311 Publications
Similar Doctors
Expertise in
17
conditions
Dr. Holly A. Shill
Neurology
Expertise in
17
conditions
Dr. Holly A. Shill
Neurology

Sjhmc Physician Services

500 W Thomas Rd, 680 Dhmg St Joseph's Pelvi, 
Phoenix, AZ 
 (0.2 miles away)
602-406-6017
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Holly Shill is a Neurologist in Phoenix, Arizona. Dr. Shill is highly rated in 17 conditions, according to our data. Her top areas of expertise are Parkinson's Disease, Essential Tremor, Movement Disorders, Deep Brain Stimulation, and Tissue Biopsy. Dr. Shill is currently accepting new patients.

Expertise in
23
conditions
Dr. Ashutosh P. Jadhav
Neurology
Expertise in
23
conditions
Dr. Ashutosh P. Jadhav
Neurology

Neurosurgical Associates Ltd

7242 E Osborn Rd, Suite 420, 
Scottsdale, AZ 
 (9.2 miles away)
480-425-8004
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashutosh Jadhav is a Neurologist in Scottsdale, Arizona. Dr. Jadhav is highly rated in 23 conditions, according to our data. His top areas of expertise are Stroke, Subarachnoid Hemorrhage, Brain Aneurysm, Thrombectomy, and Stent Placement.

Expertise in
24
conditions
Dr. Shafeeq S. Ladha
Neurology
Expertise in
24
conditions
Dr. Shafeeq S. Ladha
Neurology

Sjhmc Physician Services

500 W Thomas Rd, 680 Dhmg St Joseph's Pelvi, 
Phoenix, AZ 
 (0.2 miles away)
602-406-6017
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Shafeeq Ladha is a Neurologist in Phoenix, Arizona. Dr. Ladha is highly rated in 24 conditions, according to our data. His top areas of expertise are Pompe Disease, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Spinal Muscular Atrophy (SMA). Dr. Ladha is currently accepting new patients.

VIEW MORE Neurologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sabbagh's expertise for a condition
ConditionClose
  • Elite
  • Alzheimer's Disease
    Dr. Sabbagh is
    Elite
    . Learn about Alzheimer's Disease.
    See more Alzheimer's Disease experts
  • Dementia
    Dr. Sabbagh is
    Elite
    . Learn about Dementia.
    See more Dementia experts
  • Lewy Body Dementia (LBD)
    Dr. Sabbagh is
    Elite
    . Learn about Lewy Body Dementia (LBD).
    See more Lewy Body Dementia (LBD) experts
  • Distinguished
  • Cerebellar Degeneration
    Dr. Sabbagh is
    Distinguished
    . Learn about Cerebellar Degeneration.
    See more Cerebellar Degeneration experts
  • Down Syndrome
    Dr. Sabbagh is
    Distinguished
    . Learn about Down Syndrome.
    See more Down Syndrome experts
  • Frontotemporal Dementia
    Dr. Sabbagh is
    Distinguished
    . Learn about Frontotemporal Dementia.
    See more Frontotemporal Dementia experts
  • Memory Loss
    Dr. Sabbagh is
    Distinguished
    . Learn about Memory Loss.
    See more Memory Loss experts
  • Movement Disorders
    Dr. Sabbagh is
    Distinguished
    . Learn about Movement Disorders.
    See more Movement Disorders experts
  • Parkinson's Disease
    Dr. Sabbagh is
    Distinguished
    . Learn about Parkinson's Disease.
    See more Parkinson's Disease experts
View All 7 Distinguished Conditions
  • Advanced
  • CACH Syndrome
    Dr. Sabbagh is
    Advanced
    . Learn about CACH Syndrome.
    See more CACH Syndrome experts
  • Cerebellar Multiple System Atrophy
    Dr. Sabbagh is
    Advanced
    . Learn about Cerebellar Multiple System Atrophy.
    See more Cerebellar Multiple System Atrophy experts
  • Cerebral Amyloid Angiopathy
    Dr. Sabbagh is
    Advanced
    . Learn about Cerebral Amyloid Angiopathy.
    See more Cerebral Amyloid Angiopathy experts
  • Congenital Cardiovascular Shunt
    Dr. Sabbagh is
    Advanced
    . Learn about Congenital Cardiovascular Shunt.
    See more Congenital Cardiovascular Shunt experts
  • Deep Brain Stimulation
    Dr. Sabbagh is
    Advanced
    . Learn about Deep Brain Stimulation.
    See more Deep Brain Stimulation experts
  • Developmental Dysphasia Familial
    Dr. Sabbagh is
    Advanced
    . Learn about Developmental Dysphasia Familial.
    See more Developmental Dysphasia Familial experts
View All 17 Advanced Conditions
  • Experienced
  • Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
    Dr. Sabbagh is
    Experienced
    . Learn about Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).
    See more Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) experts
  • Anosmia
    Dr. Sabbagh is
    Experienced
    . Learn about Anosmia.
    See more Anosmia experts
  • Apraxia
    Dr. Sabbagh is
    Experienced
    . Learn about Apraxia.
    See more Apraxia experts
  • Bell's Palsy
    Dr. Sabbagh is
    Experienced
    . Learn about Bell's Palsy.
    See more Bell's Palsy experts
  • Brown Syndrome
    Dr. Sabbagh is
    Experienced
    . Learn about Brown Syndrome.
    See more Brown Syndrome experts
  • Cerebellum Agenesis Hydrocephaly
    Dr. Sabbagh is
    Experienced
    . Learn about Cerebellum Agenesis Hydrocephaly.
    See more Cerebellum Agenesis Hydrocephaly experts
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Neurologists Phoenix, AZ
  3. Dr. Marwan N. Sabbagh
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.